Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 USD | -2.17% | +6.43% | -10.78% |
05-16 | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
05-15 | Transcript : Abeona Therapeutics Inc., Q1 2024 Earnings Call, May 15, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.78% | 182M | |
+34.04% | 50.85B | |
+0.73% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.95% | 26.11B | |
-21.65% | 19.13B | |
+9.45% | 13.05B | |
+27.31% | 12.16B | |
+24.00% | 12.08B |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- HC Wainwright Adjusts Abeona Therapeutics' Price Target to $4 From $5, Keeps Buy Rating